Seek Labs
seeklabs.com
Actively hiring
Health Care
Cell & Gene Therapy
Biotechnology
As featured in
Claim pageClaim
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$16.4M
2 rounds on record
Latest round
$2.7M
Venture round · Nov 2024 · 23 mo ago
Team
36
US Form 5500 (plan participants) · Dec 2024
Hiring now
1
open roles
The money's age
Due for its next round
23 months since the last round · hiring slowed
Momentum
15/100
in the news
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Nov 26, 2024
Raised a round Venture round $2.7M · SEC Form D
Mar 19, 2024
Board appointment Seek Labs Appoints Renowned Life Sciences Innovator, Dr. Michael Paul, PhD, to Board of Directors · streetinsider.com
2024
Founded
Nov 9, 2023
Launched Seek Labs Unveils SeekIt · businesswire.com
May 30, 2023
Raised a round Venture round $13.6M · SEC Form D
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Nov 2024 | $2.7M | — | SEC Form D |
| Venture round | May 2023 | $13.6M | — | SEC Form D |
Registers and programsofficial lists and records that name the company
| Legal entity | Seek Labs, Inc. | SEC Form D |
Founders and leadersfrom filings, registers and the company's site
Jared BauerExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
backs Endura
backs Ancilia Bio
Similar startupsby what they do, their industry and backers
CRISPR-mediated viral immunity. Designed by nature, harnessed by Ancilia.
Gain unprecedented kinetic insights into your CRISPR workflow with the CRISPR QC’s analytics platform.
ScopeDx: Transforming molecular diagnostics with CRISPR-Cas.
Next-generation CAR T-cell therapies engineered to disrupt the tumor microenvironment OUR MISSION CARTemis Therapeutics is a clinical-stage…
Synvect is a CRISPR-based mosquito control solution that leverages the power of biology to eradicate disease and nuisance. Its solutions…
The RNA covalency company. Endura's small molecule drugs form an enduring bond with an mRNA, blocking translation and knocking down…
News
Seek Labs Launches Open Impact Program at Clinton Global Initiative to Advance Therapeutic Development for Neglected Infectious Diseases
SALT LAKE CITY, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Seek Labs, a TechBio company building programmable platforms to decode, program, and resolve ...
Read more
Report
Seek Labs Launches Open Impact Program at Clinton Global Initiative to Advance Therapeutic Development for Neglected Infectious Diseases
Seek Labs Launches Open Impact Program at Clinton Global Initiative to Advance Therapeutic Development for Neglected Infectious Diseases New Commitment to Action will apply Seek Labs' BioSeeker AI and Sequence Ablation Therapeutics platform to diseases hi
Read more
Report
How Better Antiviral Tactics Could Counter Antimicrobial Resistance
How Better Antiviral Tactics Could Counter Antimicrobial Resistance This article was written by Dan Ferber and originally published on disAMR on August 25, 2026. Read the original story here. It's a scenario that happens across the world, and it's a major
Read more
Report
Seek Labs Takes First Place in BioTech and Therapeutics at 2026 Utah Business Innovation Awards
Seek Labs Takes First Place in BioTech and Therapeutics at 2026 Utah Business Innovation Awards Seek Labs has been named the first-place winner in the BioTech and Therapeutics category of the 2026 Utah Business Innovation Awards, recognizing the company's
Read more
Report
NAMRU EURAFCENT Partners with Seek Labs to Advance Field-Deployable Technologies for Warfighter Readiness
NAMRU EURAFCENT Partners with Seek Labs to Advance Field-Deployable Technologies for Warfighter Readiness This article was written by Tiziana Consoli and originally published on dvidshub.net on August 24, 2026. Read the original story here. NAVAL AIR STAT
Read more
Report
Seek Labs and NAMRU EURAFCENT Enter CRADA to Evaluate Field-Deployable Diagnostics for Infectious Diseases
SALT LAKE CITY, Aug. 24, 2026 (GLOBE NEWSWIRE) -- Seek Labs, a private TechBio company building programmable platforms to decode, program, and r...
Read more
Report
Seek Labs and NAMRU EURAFCENT Enter CRADA to Evaluate Field-Deployable Diagnostics for Infectious Diseases
Seek Labs and NAMRU EURAFCENT Enter CRADA to Evaluate Field-Deployable Diagnostics for Infectious Diseases SALT LAKE CITY, UT (GlobeNewswire) - Seek Labs, a private TechBio company building programmable platforms to decode, program, and resolve diseases,
Read more
Report
AI Can Design Viruses. Can Our Defenses Adapt Fast Enough?
AI Can Design Viruses. Can Our Defenses Adapt Fast Enough? By Jared Bauer, CEO and Co-Founder, with contributions from Alison O'Mahony, Ph.D. (SVP Research and Development) and Douglas P. Gladue, Ph.D. (VP Virology) On August 6, 2026, Stanford and Arc Ins
Read more
Report
ANINA: Molecular Accuracy Without the Laboratory.
ANINA: Molecular Accuracy Without the Laboratory. How a pond in Salt Lake City led Seek Labs to replace thermal control with spatial control By Jared Bauer, CEO and Co-Founder, Seek Labs Recently, we announced the publication of research conducted by our
Read more
Report
Seek Labs Announces Publication in Nature Communications Validating ANINA, a Room-Temperature, Instrument-Free Amplification Diagnostic Technology Designed to Deliver PCR-Level Sensitivity at the Point of Need
Seek Labs Announces Publication in Nature Communications Validating ANINA, a Room-Temperature, Instrument-Free Amplification Diagnostic Technology Designed to Deliver PCR-Level Sensitivity at the Point of Need Data support SeekIt, the Company's molecular
Read more
Report
Show more news
Salary insights
Compensation ranges based on this company's open jobs
Median
$90k
Typical range
$90k
Open positions
1
1
Jobs
Middle
100%
| Level | Jobs | Median | Typical range |
|---|---|---|---|
| Middle | 1 | $90k | $90k |
Highest paying role
Communications Manager
$90k
Normalized to USD per year
People
Jared Bauer
Executive Officer, Director
Pete Koson
Director
Wayne Shore
Director
Bill Stoddart
Director
Michael Paul
Director
William Stoddart
Director
Cindy Dunkle
Director
Randy Rasmussen
Director
Peter Koson
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Growth
Hiring Momentum
28/100
Slowing
Open positions
1
0 opened / 0 closed in 30 days
ATS activity
Every ~14 hours
Today
Hiring Dynamics
0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Communications
100% ▼
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Salt Lake City
United States
HQ
Build with us.
200-500 est. staff
Salt Lake City, UT 84103